Growing Global Burden of Chronic Kidney Disease Demands Urgent Action miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
The new evidence follows the release earlier this year of a draft research plan to reassess the potential role for such screening in asymptomatic adults in the United States.
Kidney disease does not influence the benefits of the SGLT2 inhibitor empagliflozin on major HF events, even in patients at high renal risk, according to a new analysis of the EMPEROR-Pooled study. “In indicated patients, SGLT2 inhibitors should be used early in the disease process to modify cardiorenal risk and improve long-term outcomes,” Healio | Cardiology Today Editorial Board